ANIP - ANI Pharmaceuticals, Inc.

NasdaqGM - NasdaqGM Delayed Price. Currency in USD

ANI Pharmaceuticals, Inc.

210 Main Street West
Baudette, MN 56623
United States
218-634-3500
http://www.anipharmaceuticals.com

SectorHealthcare
IndustryBiotechnology
Full Time Employees143

Key Executives

NameTitlePayExercisedAge
Mr. Arthur S. PrzybylChief Exec. Officer, Pres and Director1M3.43M60
Mr. Stephen P. CareyChief Financial Officer and VP of Fin.325.86kN/A46
Mr. James G. MarkenSr. VP of Operations & Product Devel.491.05kN/A54
Mr. Robert W. SchrepferSr. VP of Bus. Devel. & Specialty Sales475.73k142.14k45
Dr. David J. Sullivan Ph.D.VP of Quality OperationsN/AN/AN/A
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

ANI Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States. It focuses on producing controlled substances, anti-cancer (oncolytics), hormones and steroids, and complex formulations. The company offers Erythromycin Ethylsuccinate to treat infections; Esterified Estrogen with Methyltestosterone for treating vasomotor symptoms of menopause; Etodolac to treat pain caused by osteoarthritis, rheumatoid arthritis, and other conditions; Fenofibrate for treating hypercholesterolemia; Flecainide to treat arrhythmia; Fluvoxamine for treating obsessive-compulsive and social anxiety disorders; and Hydrocortisone Enema and Cortenema to treat ulcerative colitis. It also provides Hydrocortisone Rectal Cream to treat inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses; Lithium Carbonate ER and Lithobid for bipolar disorder; Mesalamine Enema to treat distal ulcerative colitis, proctosigmoiditis, or proctitis; Methazolamide to treat ocular conditions; and Metoclopramide and Reglan to treat gastroesophageal reflux. In addition, the company offers Nilutamide to treat metastatic prostate cancer; Nimodipine that reduces the ischemic deficits in patients with subarachnoid hemorrhage; Opium Tincture to treat diarrhea; Oxycodone capsules and oral solution for pain; Propafenone to treat arrhythmia; Propranolol ER and Inderal LA for managing hypertension in patients with angina pectoris; and Vancomycin and Vancocin for use in treating C. difficile-associated diarrhea and enterocolitis. Further, it provides contract manufacturing services for other pharmaceutical companies. The company markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations. ANI Pharmaceuticals, Inc. is headquartered in Baudette, Minnesota.

Corporate Governance

ANI Pharmaceuticals, Inc.’s ISS Governance QualityScore as of February 1, 2018 is 2. The pillar scores are Audit: 1; Board: 4; Shareholder Rights: 1; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.